Repligen
Repligen
Revolutionizing ADC Manufacturing for Safer Cancer Treatments!
Discover how Repligen's integrated solutions are revolutionizing ADC manufacturing, enhancing safety, efficiency, and real-time analytics for better cancer treatments! 🧪📊✨
Repligen and Novasign Join Forces for Smart Bioprocessing!
Repligen and Novasign team up! 🤝✨ Together, they’re advancing bioprocessing digitalization with machine learning and digital twin technology. 💡🔍
Boosting Vaccine Production: Real-Time Monitoring Revolution!
🌟 Repligen and Univercells are teaming up to revolutionize viral vector production with real-time monitoring for enhanced vaccine development! 📈🔍⚙️
Repligen’s $70M Deal Boosts Bioprocessing Tech!
Repligen acquires 908 Devices' bioprocessing analytics for $70M! 💰📊 Enhancing PAT offerings and manufacturing efficiency! 🤝🔍 Biotech Innovation
Repligen to Boost Bioprocessing with Tantti Acquisition!
**Excerpt:** 🌟 Repligen is set to acquire Tantti Laboratory, enhancing purification of biologics with innovative chromatography beads! 🧬📈 Exciting growth ahead! 🔜
Revolutionary Partnership: Purolite and Repligen Transform mAbs Purification Process
💡 Purolite and Repligen collaborate on advanced chromatography resins for efficient purification of mAbs in biopharmaceutical production.🔬💉
